Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis

被引:71
|
作者
Abraham, Jerrold L. [1 ]
Thakral, Charu [1 ]
机构
[1] Upstate Med Univ, SUNY Albany, Dept Pathol, Syracuse, NY 13210 USA
关键词
gadolinium; transmetallation; biodistribution; toxicology; scanning electron microscopy; tissue microanalysis;
D O I
10.1016/j.ejrad.2008.01.026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Gadolinium (Gd) released from Gd-based MR contrast agents is the likely etiologic agent of nephrogenic systemic fibrosis (NSF). The biodistribution and kinetics of both chelated Gd and free Gd3+ are reviewed, including demonstrations of Gd in tissues of NSF patients. The purpose of this review is to consolidate the available information on distribution, metabolism, excretion and retention of Gd with particular emphasis on the possible mechanisms in the development of NSF. We also raise serious concern about the growing tissue burden of Gd with the release of Gd from its chelates and its yet unknown consequences. The development of NSF as well as potential long-term consequences of tissue Gd retention represent a part of the spectrum of Gd toxicity. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:200 / 207
页数:8
相关论文
共 50 条
  • [1] Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Boyd, Alan S.
    Sanyal, Soma
    Abraham, Jerrold L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (02) : 337 - 342
  • [2] Gadolinium and nephrogenic systemic fibrosis
    Fisa Ramos, Ivan
    Soler, Ana
    Bonet, Teresa
    Escacena, Monica
    Duch, Jonathan
    IMAGEN DIAGNOSTICA, 2013, 4 (01): : 29 - 32
  • [3] Nephrogenic Systemic Fibrosis: Histology and Gadolinium Detection
    Thakral, Charu
    Abraham, Jerrold L.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2009, 47 (05) : 841 - +
  • [4] Gadolinium and nephrogenic systemic fibrosis: an update
    Alex Weller
    Joy L Barber
    Øystein E Olsen
    Pediatric Nephrology, 2014, 29 : 1927 - 1937
  • [5] Nephrogenic systemic fibrosis - gadolinium disease?
    Economidou, D.
    Pateinakis, P.
    ARCHIVES OF HELLENIC MEDICINE, 2009, 26 (05): : 593 - 600
  • [6] Gadolinium and nephrogenic systemic fibrosis: an update
    Weller, Alex
    Barber, Joy L.
    Olsen, Oystein E.
    PEDIATRIC NEPHROLOGY, 2014, 29 (10) : 1927 - 1937
  • [7] Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue
    Wiginton, Clark D.
    Kelly, Brent
    Oto, Aytekin
    Jesse, Mary
    Aristimuno, Patricia
    Ernst, Randy
    Chaljub, Gregory
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (04) : 1060 - 1068
  • [8] Nephrogenic systemic fibrosis associated with gadolinium use
    Chao, Chi-Chao
    Yang, Chih-Chao
    Hsiao, Cheng-Hsiang
    Pan, Ming-Kai
    Lin, Chin-Hsuan
    Hsieh, Sung-Tsang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2008, 107 (03) : 270 - 274
  • [9] Gadolinium and nephrogenic systemic fibrosis: Association or causation
    Kurtkot, Jagadeesh
    Snow, Thomas
    Hiremagalur, Balaji
    NEPHROLOGY, 2008, 13 (03) : 235 - 241
  • [10] Nephrogenic systemic fibrosis: An epidemic of gadolinium toxicity
    Todd D.J.
    Kay J.
    Current Rheumatology Reports, 2008, 10 (3) : 195 - 204